OphSourceHomeJournal CollectionOphSource ShopEvents
Journal Home
Search for

Volume 110, Issue 7, Pages 1391-1395 (July 2003)


View previous. 35 of 48 View next.

Three-year follow-up of the artisan phakic intraocular lens for hypermetropia

Ruchi Saxena, MS1, Monika Landesz, MD, PhD2, Bastiaantje Noordzij1, Gregorius P.M Luyten, MD, PhD1Corresponding Author Information

Received 9 October 2001; accepted 13 December 2002.

Abstract 

Purpose

We report the postoperative results of the Artisan Hyperopia phakic intraocular lens (IOL; model 203W; Ophtec, Groningen, The Netherlands).

Design

Prospective, nonrandomized trial.

Participants

Twenty-six eyes of 13 self-selected patients with refractive error ranging from +3.00 to +11.00 diopters (D).

Intervention

Patients with hypermetropia were implanted with the Artisan Hyperopia phakic IOL. Mean follow-up was 22.4 months (range, 3–36 months).

Main outcome measures

Predictability, stability, efficacy, loss of best spectacle-corrected visual acuity, and complications.

Results

At six months, 90.9% (20 of 22 eyes) were ±1.00 D of intended correction and 81.8% (18 eyes) were ±1.00 D of emmetropia. The mean spherical equivalent was stable within 0.25 D during the entire 3-year follow-up period. Twenty-four eyes (92.3%) had a postoperative best spectacle-corrected visual acuity of 0.50 or better at all of their individual follow-up examinations. No patient lost 2 or more lines after the procedure. There was a significant negative correlation between anterior chamber depth and endothelial cell loss. Two patients experienced posterior synechiae with pigment deposits in both eyes. One of these patients had convex irides and underwent implant removal within 2 years with a consequent clear lens extraction and posterior chamber lens implantation.

Conclusions

Implantation of the Artisan Hyperopic lens leads to accurate and stable refractive results with no significant loss of vision. More attention should be paid to convex irides and shallow anterior chambers during the preoperative screening to avoid unnecessary complications.

1 Department of Ophthalmology, Erasmus MC, Rotterdam, The Netherlands

2 Vision Clinics, Medical Center Rotterdam Airport, Rotterdam, The Netherlands

Corresponding Author InformationCorrespondence to Gregorius P. M. Luyten, MD, PhD, Department of Ophthalmology, Erasmus MC, Dr. Molenwaterplein 40, 3015 GD Rotterdam, The Netherlands.

 Manuscript no. 210851

The authors have no proprietary or financial interest in any of the products or equipment mentioned.

PII: S0161-6420(03)00405-6

doi:10.1016/S0161-6420(03)00405-6


View previous. 35 of 48 View next.